Scientists from WuXi STA and our partner Kura Oncology published this OPR&D paper discussing a new process for commercial-scale production of Tipifarnib that dramatically reduced waste disposal and increased output by 60%.
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.